IKZF1 deletion is enriched in pediatric B-cell precursor acute lymphoblastic leukemia patients showing prednisolone resistance

被引：0
|
作者：
T Imamura
M Yano
D Asai
A Moriya-Saito
S-I Suenobu
D Hasegawa
T Deguchi
Y Hashii
H Kawasaki
H Hori
K Yumura-Yagi
J Hara
K Horibe
A Sato
机构：
[1] Kyoto Prefectural University of Medicine,Department of Pediatrics
[2] Graduate School of Medical Science,Division of General Pediatrics and Emergency Medicine, Department of Pediatrics
[3] Japan Association of Childhood Leukemia Study Group (JACLS),Department of Hematology/Oncology
[4] Clinical Research Center,Department of Pediatrics
[5] National Hospital Organization Nagoya Medical Center,Department of Pediatrics
[6] Oita University,Department of Pediatrics
[7] Hyogo Prefectural Children’s Hospital,Department of Pediatric Hematology/Oncology
[8] Mie University,Department of Hematology and Oncology
[9] Osaka University,undefined
[10] Kansai Medical University,undefined
[11] Yumura Clinic,undefined
[12] Osaka City General Hospital,undefined
[13] Miyagi Children’s Hospital,undefined
来源：
Leukemia | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1801 / 1803
页数：2
相关论文
共 50 条
  • [1] IKZF1 deletion is enriched in pediatric B-cell precursor acute lymphoblastic leukemia patients showing prednisolone resistance
    Imamura, T.
    Yano, M.
    Asai, D.
    Moriya-Saito, A.
    Suenobu, S-I
    Hasegawa, D.
    Deguchi, T.
    Hashii, Y.
    Kawasaki, H.
    Hori, H.
    Yumura-Yagi, K.
    Hara, J.
    Horibe, K.
    Sato, A.
    LEUKEMIA, 2016, 30 (08) : 1801 - +
  • [2] IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
    Asai, Daisuke
    Imamura, Toshihiko
    Suenobu, So-ichi
    Saito, Akiko
    Hasegawa, Daiichiro
    Deguchi, Takao
    Hashii, Yoshiko
    Matsumoto, Kimikazu
    Kawasaki, Hirohide
    Hori, Hiroki
    Iguchi, Akihiro
    Kosaka, Yoshiyuki
    Kato, Koji
    Horibe, Keizo
    Yumura-Yagi, Keiko
    Hara, Junichi
    Oda, Megumi
    CANCER MEDICINE, 2013, 2 (03): : 412 - 419
  • [3] Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia
    Pan, Lili
    Chen, Yiqiao
    Weng, Kaizhi
    Guo, Biyun
    Zhuang, Shuquan
    Huang, Shuxian
    Lian, Zhulan
    Wang, Xiaofang
    Li, Nainong
    Zheng, Yongzhi
    BMC CANCER, 2024, 24 (01)
  • [4] Unraveling IKZF1 Deletion Therapeutic Vulnerabilities in Adult B-Cell Precursor Acute Lymphoblastic Leukemia
    Ribera, Jordi
    Morgades, Mireia
    Malinverni, Roberto
    Zamora, Lurdes
    Vives, Susana
    Batlle, Montserrat
    Torrent, Anna
    Chapchap, Eduardo
    Garcia, Olga
    Mallo, Mar
    Granada, Isabel
    Ruiz-Xiville, Neus
    De Haro, Nuri
    Gonzalez-Gil, Celia
    Genesca, Eulalia
    Coll, Rosa
    Mercadal, Santiago
    Escoda, Lourdes
    Montesinos, Pau
    Gomez-Segui, Ines
    Pratcorona, Marta
    Nomdedeu, Josep
    Tormo, Mar
    Martinez-Lopez, Joaquin
    Barba, Pere
    Esteve, Jordi
    Gonzalez-Campos, Jose
    Ciudad, Juana
    Barrena, Susana
    Buschbeck, Marcus
    Sole, Francesc
    Feliu, Evarist
    Orfao, Alberto
    Maria Hernandez-Rivas, Jesus
    Maria Ribera, Josep
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S167 - S167
  • [5] The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
    Marke, Rene
    van Leeuwen, Frank N.
    Scheijen, Blanca
    HAEMATOLOGICA, 2018, 103 (04) : 565 - 574
  • [6] IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia
    Vervoort, Britt M. T.
    Butler, Miriam
    Grunewald, Kari J. T.
    Schenau, Dorette S. van Ingen
    Tee, Trisha M.
    Lucas, Luc
    Huitema, Alwin D. R.
    Boer, Judith M.
    Bornhauser, Beat C.
    Bourquin, Jean-Pierre
    Hoogerbrugge, Peter M.
    van der Velden, Vincent H. J.
    Kuiper, Roland P.
    van der Meer, Laurens T.
    van Leeuwen, Frank N.
    HAEMATOLOGICA, 2024, 109 (12) : 3904 - 3917
  • [7] Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia
    R Marke
    J Havinga
    J Cloos
    M Demkes
    G Poelmans
    L Yuniati
    D van Ingen Schenau
    E Sonneveld
    E Waanders
    R Pieters
    R P Kuiper
    P M Hoogerbrugge
    G J L Kaspers
    F N van Leeuwen
    B Scheijen
    Leukemia, 2016, 30 : 1599 - 1603
  • [8] IKZF1 DELETION AND PROGNOSIS OF ADULTS WITH COMMON B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Yao, Q. -M.
    Liu, K. -Y.
    Gale, R. P.
    Jiang, B.
    Liu, Y. -R.
    Jiang, Q.
    Jiang, H.
    Zhang, X. -H.
    Chen, S. -S.
    Huang, X. -J.
    Xu, L. -P.
    Ruan, G. -R.
    HAEMATOLOGICA, 2015, 100 : 203 - 203
  • [9] Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia
    Marke, R.
    Havinga, J.
    Cloos, J.
    Demkes, M.
    Poelmans, G.
    Yuniati, L.
    Schenau, D. van Ingen
    Sonneveld, E.
    Waanders, E.
    Pieters, R.
    Kuiper, R. P.
    Hoogerbrugge, P. M.
    Kaspers, G. J. L.
    van Leeuwen, F. N.
    Scheijen, B.
    LEUKEMIA, 2016, 30 (07) : 1599 - 1603
  • [10] Cooperative Genetic Changes in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia with Deletions or Mutations of IKZF1
    Olsson, Linda
    Albitar, Ferras
    Castor, Anders
    Behrendtz, Mikael
    Biloglav, Andrea
    Paulsson, Kajsa
    Johansson, Bertil
    GENES CHROMOSOMES & CANCER, 2015, 54 (05): : 315 - 325
12345